Subscribe to RSS
Covalent Inhibition of Ras G12C with a Stapled Peptidomimetic
Covalent Targeting of Ras G12C by Rationally Designed Peptidomimetics.
ACS Chem. Biol. 2020;
21 July 2020 (online)
Ras proteins are central to several pathways involved in cell proliferation and survival. Dysregulation in Ras signaling is implicated in nearly 30% of all human tumors, and therefore represents an important target in oncology. Bar-Sagi, Arora, and co-workers describe the development of a covalent inhibitor of mutant Ras G12C, using a stapled peptidomimetic scaffold based on the nucleotide exchange factor Son of Sevenless (SoS).
Inhibitor A was synthesized using SPPS and includes an interesting hydrogen-bond surrogate (HBS) motif that is generated from an on-resin ring-closing metathesis of an internal N-allyl glycine to an N-terminal hexenoic amide. Binding of A to Ras G12C triggers proximity-induced cysteine alkylation of A’s sulfonamide motif. Biochemical assays indicate that the G12C mutation is necessary for Ras inhibition and modulation of downstream effects by A.